AvantiCell Science Ltd

Where the EU money came from

Funding by EU programme. Amounts are AvantiCell Science Ltd's own share of each project, not the project's full budget.

Projects

13 EU-funded projects, newest first. AvantiCell Science Ltd led 3 of them as coordinator. Each links to the official record.

• EuroNeurotrophinPartner

  A European training network for the discovery of neurotrophins small molecule mimetics as candidate therapeutic agents for neurodegeneration and neuroinflammation

  Horizon 2020 · 2018–2022 · Project on CORDIS ↗

  €195ktheir share
• TRANSMITPartner

  TRANSlating the role of Mitochondria in Tumorigenesis

  Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  €213ktheir share
• CENSUSCoordinator

  Cell-Based Models for Neurodegeneration Study and Use in Screening

  Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  €676ktheir share
• PANDORAPartner

  Probing safety of nano-objects by defining immune responses of environmental organisms

  Horizon 2020 · 2016–2019 · Project on CORDIS ↗

  €273ktheir share
• ANAPRINTCoordinator

  Additive Printing for Cell-Based Analysis

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  €1.3Mtheir share
• Chromatin3DPartner

  Chromatin Dynamics in Development and Disease

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗

  €273ktheir share
• ANAPRINTCoordinator

  Additive Printing for Cell-based Analysis

  Horizon 2020 · 2014–2015 · Project on CORDIS ↗

  €50ktheir share
• NEXTPartner

  Nano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €875ktheir share
• PathChooserPartner

  Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €282ktheir share
• BIOSIDPartner

  A bioartificial pancreas to treat type 1 diabetes: optimization of cell survival and function in preclinical and clinical phases

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

  €485ktheir share
• HUMUNITYPartner

  Cell-Based Models of Human Mucosal Immunity with Multiple Commercial Applications

  FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

  €531ktheir share
• NANOTOESPartner

  Nanotechnology: Training Of Experts in Safety

  FP7 (2007 to 2013) · 2010–2015 · Project on CORDIS ↗

  €238ktheir share
• MAGISTERPartner

  Magnetic Scaffolds for in vivo Tissue Engineering

  FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

  €245ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Consiglio Nazionale Delle RicercheItaly · 4 shared projects
• The University of EdinburghUnited Kingdom · 2 shared projects
• Karolinska InstitutetSweden · 2 shared projects
• Alma Mater Studiorum - Universita di BolognaItaly · 2 shared projects
• University College Dublin, National University of Ireland, DublinIreland · 2 shared projects
• Idryma Technologias Kai ErevnasGreece · 2 shared projects
• Universite Catholique de LouvainBelgium · 2 shared projects
• Ruprecht-Karls-Universitaet HeidelbergGermany · 2 shared projects
• Fundacio Institut Catala de Nanociencia i NanotecnologiaSpain · 2 shared projects
• Paris-Lodron-Universitat SalzburgAustria · 2 shared projects
• University of BrightonUnited Kingdom · 2 shared projects
• Explora SRLItaly · 2 shared projects
• Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 1 shared project
• Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 1 shared project
• The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• additive manufacturing
• amorphous semiconductors
• artificial pancreas
• biomaterials
• biomolecules
• business models
• census
• chromosomes
• diabetes
• drug discovery
• enzymes
• glaucoma